ABN AMRO Bank N.V.

Bank

Position in MRK — Merck & Co., Inc.

CIK 1561082 AMSTERDAM, P7

Position in MRK

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$17,727,979

-$2,462,046 QoQ

Shares Held

147,377

-23.2% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

ABN AMRO Bank N.V. holds $948,098,619 across 8 Drug Manufacturers - General names. MRK ranks #5 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	2,445,171	$482,236,624
2	LLY	ELI LILLY & Co	239,700	$220,468,869
3	ABBV	AbbVie Inc.	864,389	$187,995,963
4	GILD	Gilead Sciences, Inc.	195,724	$27,278,053
5	MRK	Merck & Co., Inc. This page	147,377	$17,727,979
6	JNJ	Johnson & Johnson	37,023	$9,049,902
7	AMGN	Amgen Inc	5,506	$1,937,286
8	PFE	Pfizer Inc	49,998	$1,403,943

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,727,979	147,377	-23.2%	Shares	Sole	2026-04-22
2025-12-31	$20,190,025	191,811	-90.0%	Shares	Sole	2026-02-04
2025-09-30	$161,061,837	1,919,002	+2.0%	Shares	Sole	2025-11-05
2025-06-30	$148,905,501	1,881,070	-0.0%	Shares	Sole	2025-08-12
2025-03-31	$168,876,977	1,881,428	-32.7%	Shares	Sole	2025-08-28
2024-12-31	$278,066,496	2,795,200	+0.7%	Shares	Sole	2025-08-28
2024-09-30	$315,090,162	2,774,658	+16.1%	Shares	Sole	2025-08-28
2024-06-30	$295,811,805	2,389,433	+11.4%	Shares	Sole	2025-08-28
2024-03-31	$283,142,796	2,145,834	+0.2%	Shares	Sole	2025-08-28
2023-12-31	$233,438,093	2,141,241	+2.6%	Shares	Sole	2025-08-28
2023-09-30	$214,750,920	2,085,973	-1.2%	Shares	Sole	2025-08-28
2023-06-30	$243,662,370	2,111,642	-1.2%	Shares	Sole	2025-08-28
2023-03-31	$227,439,265	2,137,788	—	Shares	Sole	2025-08-28
No filing history on record for this holder in this stock.